德拉维特综合征发作频率和聚类:临床试验中接受安慰剂治疗的患者
Rima Nabbout1, Kerry Hyland2, Rachael Loftus2
1Reference Centre for Rare Epilepsies, Department of Pediatric Neurology, Necker Enfants Malades Hospital, Universite Paris Cité, Paris, France; Imagine Institute UMR1163, Paris, France.
Epilepsy & behavior : E&B
|April 21, 2024
概括
在德拉维特综合征中,发作群的频率可能会受到年龄和体重指数 (BMI) 的影响. 了解这些因素可以帮助改善这种罕见的临床试验设计.
科学领域:
- 神经学 神经学
- 发病学 (Epileptology) 是一个专业的学科.
- 临床试验 临床试验
背景情况:
- 德拉维特综合征是一种严重的,耐治疗的,与和集团相关的显著发病率和死亡率风险.
- 了解发作模式和可变性对于改善临床试验设计和患者结果至关重要.
研究的目的:
- 探索发作类型,发作集群,以及影响Dravet综合征患者发作集群变异性的因素.
- 为了确定患者特征和集群频率之间的潜在相关性.
主要方法:
- 来自两个III期临床试验 (GWPCARE 1B和GWPCARE 2) 的安慰剂治疗患者 (2-18岁) 的综合后期分析.
- 在日志转换的发作集群频率上对共变量的多变量阶段性分析.
- 计算体重和体重指数 (BMI) 的z分数和不良事件的评估.
主要成果:
- 分析包括3个年龄组 (2-5,6-12,13-18岁) 的124名安慰剂治疗患者.
- 通用性强力克隆和肌肉克隆性发作是最常见的类型.
- 发作集群频率总体下降,但在不同年龄组显示出差异. 多变量分析表明与年龄有正相关性,与BMI有负相关性.
结论:
- 在Dravet综合征中的BMI,年龄和发作集群变异之间存在潜在的关系.
- 发作集群频率可能在未来的临床试验中作为一个有价值的结果指标.
- 需要进一步的研究来验证这些发现.
相关概念视频
01:13Seizures: Classification
339
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
339
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
288
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
288
01:20Antiepileptic Drugs: Potassium Channel Activators
176
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
176
01:24Arteries of the Lower Limbs
188
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
188
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
388
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
388
01:08Antiepileptic Drugs: Sodium Channel Blockers
522
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
522